(Q41021406)

25 September 2017

title

S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways (English)

1 reference

25 September 2017

1 reference

Rui Wu

1

1 reference

25 September 2017

Liang Duan

2

1 reference

25 September 2017

Fang Cui

3

1 reference

25 September 2017

Ju Cao

4

1 reference

25 September 2017

Yu Xiang

5

1 reference

25 September 2017

Yishu Tang

6

1 reference

25 September 2017

Lan Zhou

7

1 reference

25 September 2017

language of work or name

English

0 references

publication date

20 April 2015

1 reference

Experimental Cell Research

25 September 2017

published in

1 reference

25 September 2017

volume

334

1 reference

25 September 2017

issue

2

1 reference

25 September 2017

page(s)

228-238

1 reference

25 September 2017

cites work

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Immune pathogenesis of hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Molecular pathogenesis of human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Hepatocellular carcinoma pathogenesis: from genes to environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Multiple interactive factors in hepatocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Molecular hepatic carcinogenesis: impact of inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Relating form and function of EF-hand calcium binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

HaCaT Keratinocytes Overexpressing the S100 Proteins S100A8 and S100A9 Show Increased NADPH Oxidase and NF-κB Activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Clinicopathological roles of S100A8 and S100A9 in cutaneous squamous cell carcinoma in vivo and in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Immunohistochemical investigation of migration inhibitory factor-related protein (MRP)-14 expression in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

S100A8/A9 activate key genes and pathways in colon tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Cell adhesion molecules and their relation to (cancer) cell stemness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Myeloid-derived suppressor cells as regulators of the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

S100A8 and S100A9: new insights into their roles in malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

The role of cAMP-MAPK signalling in the regulation of human hepatocellular carcinoma growth in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Molecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPK

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

S100P, a peculiar member of S100 family of calcium-binding proteins implicated in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-κB-dependent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Mitogen-activated protein kinases in hepatocellular carcinoma development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Reprogramming and carcinogenesis--parallels and distinctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Cancer stem cells: an old idea--a paradigm shift

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Adult stem cells and their trans-differentiation potential--perspectives and therapeutic applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Cancer stem cells are enriched in the side population cells in a mouse model of glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.04.008

10.1016/J.YEXCR.2015.04.008

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference